Invention Grant
- Patent Title: Phosphoramidate alkylator prodrugs for the treatment of cancer
- Patent Title (中): 用于治疗癌症的磷酰胺酸烷基酯前体药物
-
Application No.: US12521290Application Date: 2007-12-21
-
Publication No.: US08552048B2Publication Date: 2013-10-08
- Inventor: Steve Ammons , Jian-Xin Duan , Donald Jung , Mark Matteucci
- Applicant: Steve Ammons , Jian-Xin Duan , Donald Jung , Mark Matteucci
- Applicant Address: US CA South San Francisco
- Assignee: Threshold Pharmaceuticals, Inc.
- Current Assignee: Threshold Pharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Kilpatrick Townsend & Stockton LLP
- International Application: PCT/US2007/088645 WO 20071221
- International Announcement: WO2008/083101 WO 20080710
- Main IPC: A01N57/00
- IPC: A01N57/00 ; A01N57/26 ; A61K31/675 ; A61K31/66
Abstract:
Compositions containing, and, methods administering, TH302, are useful in treatment of cancer and other hyper-proliferative diseases.
Public/Granted literature
- US20100183742A1 PHOSPHORAMIDATE ALKYLATOR PRODRUGS FOR THE TREATMENT OF CANCER Public/Granted day:2010-07-22
Information query
